Poland· PL-100406696
Sodium oxybate Accord
A sodium oxybate product containing natrii hydroxybutyras, registered in Poland by Accord Healthcare Polska Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sodium oxybate is registered in 14 of 19 countries.
Countries holding a registration under ATC N07XX04 (sodium oxybate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Sodium oxybate · ATC N07XX04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Natrii hydroxybutyras
- Manufacturer
- Accord Healthcare Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- N07XX04
- ATC class
- Sodium oxybate
- Defined daily dose
- 7.5 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991425265
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
65 interactions on record for sodium oxybate.
Graded by severity as the source publishes them — 54 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sodium oxybate · interactions on record
65 records
- 54 severe
- 11 moderate
Most severe, free to view
- MetoclopramideA03FA01severe
- ThiethylperazinA04AB03severe
- DiphenhydraminA04AB05severe
- DronabinolA04AD10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sodium oxybate in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/63b4860c-0e8a-4848-bb90-e47f22d661e3 GET /v1/drugs/63b4860c-0e8a-4848-bb90-e47f22d661e3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór doustny",
"source": "urpl",
"strength": "500 mg/ml",
"packaging": "05909991425265 ¦ Rpz ¦ 135581\n1 butelka 180 ml",
"substance": "Natrii hydroxybutyras 500 mg/ml",
"common_name": "Natrii hydroxybutyras",
"pl_product_id": "100406696",
"pozwolenie_nr": "25776",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about sodium oxybate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.